Related Experiment Video
Updated: Feb 17, 2026
05:10
Induction of Retinal Ischemia-Reperfusion Injury in a Mouse Eye Model
Published on: December 20, 2024
1.2K
Neurosurgical Modeling of Retinal Ischemia-Reperfusion Injury.
Alireza P Shabanzadeh1, Philippe M D'Onofrio2, Philippe P Monnier3
1Division of Anatomy, Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.
Summary
A new pterygopalatine-ophthalmic artery clamping (OAC) model effectively replicates retinal ischemia-reperfusion injury. This reproducible model aids in testing neuroprotective therapies for stroke by mimicking human ophthalmic artery occlusion.
Area of Science:
- Ophthalmology
- Neuroscience
- Vascular Biology
Background:
- Developing reliable models for retinal ischemia-reperfusion injury is crucial for evaluating neuroprotective treatments for stroke.
- A novel, reproducible pterygopalatine-ophthalmic artery ligation model was developed to induce ischemia-reperfusion injury in the retina.
Purpose of the Study:
- To introduce and validate a new method for creating retinal ischemia-reperfusion injury.
- To compare the efficacy of the new pterygopalatine-ophthalmic artery clamping (OAC) model with the standard ophthalmic artery/meningeal sheath ligation (OAML) model.
Main Methods:
- Rats underwent either OAML or OAC for 30 minutes.
- Retinal ganglion cell (RGC) survival was assessed using FluoroGold (FG) and RNA-binding protein with multiple splicing (RBPMS) labeling 14 days post-ischemia.
- Results were compared against a sham group.
Main Results:
- Both OAML and OAC significantly reduced RGC density compared to sham groups (P < .001).
- OAC and OAML induced comparable levels of RGC damage.
- The OAC model demonstrated less variability in RGC survival compared to the OAML model.
Conclusions:
- The OAC procedure reliably reproduces ischemia-reperfusion injury, mimicking human ophthalmic artery occlusion.
- This new model offers a valuable tool for researching interventions targeting RGC ischemic degeneration.
